Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

XCUR

Exicure Inc

Oct 04 • 04:00PM ET

2.70

Dollar change -0.07
Percentage change -2.53	%

Healthcare • Biotechnology • USA • NASD

Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.72	Insider Own	61.84%	Shs Outstand	1.73M	Perf Week	-25.82%
Market Cap	4.67M	Forward P/E	-	EPS next Y	-	Insider Trans	28.49%	Shs Float	0.66M	Perf Month	44.39%
Income	-8.17M	PEG	-	EPS next Q	-	Inst Own	2.95%	Short Float	4.93%	Perf Quarter	78.51%
Sales	0.50M	P/S	9.34	EPS this Y	-	Inst Trans	-4.56%	Short Ratio	0.02	Perf Half Y	-3.55%
Book/sh	0.93	P/B	2.90	EPS next Y	-	ROA	-57.87%	Short Interest	0.03M	Perf Year	-26.03%
Cash/sh	0.31	P/C	8.81	EPS next 5Y	-	ROE	-144.41%	52W Range	1.44 - 6.00	Perf YTD	-6.94%
Dividend Est.	-	P/FCF	-	EPS past 5Y	33.58%	ROI	-112.61%	52W High	-55.00%	Beta	1.29
Dividend TTM	-	Quick Ratio	0.61	Sales past 5Y	1609.08%	Gross Margin	-87.20%	52W Low	87.50%	ATR (14)	0.52
Dividend Ex-Date	-	Current Ratio	0.61	EPS Y/Y TTM	-173.77%	Oper. Margin	-1193.20%	RSI (14)	48.53	Volatility	10.84% 18.41%
Employees	6	Debt/Eq	4.55	Sales Y/Y TTM	-97.90%	Profit Margin	-1634.40%	Recom	3.00	Target Price	10.00
Option/Short	No / Yes	LT Debt/Eq	3.50	EPS Q/Q	89.85%	Payout	-	Rel Volume	0.01	Prev Close	2.77
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	May 16 AMC	Avg Volume	1.37M	Price	2.70
SMA20	-3.23%	SMA50	10.51%	SMA200	4.25%	Trades		Volume	13,346	Change	-2.53%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-13-21	Downgrade	Chardan Capital Markets	Buy → Neutral	$2.25 → $0.40
Dec-18-20	Initiated	BMO Capital Markets	Outperform	$6
Nov-20-19	Initiated	Guggenheim	Buy	$9

Sep-18-24 04:01PM	Exicure, Inc. Receives Extension from Nasdaq Hearings Panel (Business Wire) +71.62%
Sep-09-24 06:53PM	Exicure, Inc. Announces Proposed Settlement of Securities Class Action Litigation (Business Wire)
Aug-26-24 09:08AM	Exicure, Inc. Announces 1-for-5 Reverse Stock Split (Business Wire) -9.52%
Aug-19-24 10:31AM	Exicure, Inc. Announces Additional Adjournment of Special Meeting and Information for Reconvened Special Meeting (Business Wire) +9.83%
Aug-15-24 10:31AM	Exicure, Inc. Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting (Business Wire)
04:01PM	Loading…
Aug-13-24 04:01PM	Exicure, Inc. Reports Second Quarter 2024 Financial Results (Business Wire) -25.57%
Aug-08-24 04:27PM	Exicure, Inc. Recruits Head of Corporate Development and Bioinformatics (Business Wire) +6.48%
Aug-02-24 07:34AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace) +33.76%
Aug-01-24 04:01PM	Exicure, Inc. Receives Positive Listing Determination from Nasdaq (Business Wire) +12.97%
Jul-26-24 07:36AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Jun-17-24 09:53PM	XCUR Stock Earnings: Exicure Reported Results for Q1 2024 (InvestorPlace)
04:01PM	Exicure, Inc. Reports First Quarter 2024 Financial Results (Business Wire)
Jun-06-24 09:52PM	XCUR Stock Earnings: Exicure Reported Results for Q4 2023 (InvestorPlace) -5.30% -16.35%
04:01PM	Exicure, Inc. Reports Full Year 2023 Financial Results (Business Wire)
May-29-24 07:39AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace) +11.05%
04:01PM	Loading…
May-23-24 04:01PM	Exicure, Inc. Received Nasdaq Notice of a Delisting Determination (Business Wire) -26.34%
May-16-24 09:52PM	XCUR Stock Earnings: Exicure Reported Results for Q3 2023 (InvestorPlace)
04:08PM	Exicure, Inc. Reports Third Quarter 2023 Financial Results (Business Wire)
Apr-22-24 04:01PM	Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K (Business Wire)
Feb-06-24 07:05AM	Exicure and Bluejay sign hepatitis treatment development deal (Pharmaceutical Business Review) +27.59%
Feb-05-24 04:01PM	Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis (Business Wire)
Dec-08-23 08:40AM	Why Is Exicure (XCUR) Stock Up 57% Today? (InvestorPlace) +28.59%
Nov-28-23 04:01PM	Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q (Business Wire) -6.00%
Aug-23-23 09:48AM	Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors (Business Wire)
Aug-11-23 04:01PM	Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update (Business Wire)
Jul-14-23 04:01PM	Exicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update (Business Wire) +7.94%
May-26-23 04:01PM	Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives (Business Wire)
May-19-23 04:01PM	Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q (Business Wire) -9.13%
May-04-23 04:01PM	Exicure, Inc. Announces Investment in Korean SNS Platform Cyworld (Business Wire)
Apr-27-23 07:00AM	Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors (Business Wire)
04:01PM	Loading…
Mar-27-23 04:01PM	Exicure, Inc. Reports Full Year 2022 Financial Results and Provides Corporate Update (Business Wire) -5.26% -10.84%
Feb-24-23 05:10PM	Exicure, Inc. Announces Closing of Private Placement Transaction with CBI USA, Inc. and Changes to the Board of Directors (Business Wire) +7.02%
Dec-14-22 05:00AM	Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements (Business Wire)
Nov-14-22 04:01PM	Exicure, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update (Business Wire) -8.73%
Sep-26-22 04:01PM	Exicure, Inc. Enters Into Definitive Agreement With CBI USA, Inc. for $5.4 Million Equity Financing and Announces Implementation of Strategic Measure to Reduce Cash Burn and Prioritize Strategic Alternatives (Business Wire) +10.39% -17.06%
Sep-01-22 07:00AM	Exicure Announces Presentation at Chardans 6th Annual Genetic Medicines Conference (Business Wire)
Aug-15-22 04:01PM	Exicure, Inc. Reports Second Quarter 2022 Financial Results and Corporate Progress (Business Wire)
Jul-20-22 04:01PM	Exicure, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement (Business Wire)
Jun-29-22 12:00PM	Exicure, Inc. Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split (Business Wire) -27.81%
May-27-22 04:01PM	Exicure, Inc. Announces Adjournment of Annual Meeting of Stockholders (Business Wire) +6.69%
May-17-22 07:00AM	Exicure Announces Presentation at 2022 H.C. Wainwright Global Life Sciences Conference (Business Wire) +9.21%
May-16-22 04:01PM	Exicure, Inc. Reports First Quarter 2022 Financial Results and Corporate Progress (Business Wire) -6.19%
May-10-22 07:21PM	Exicure Announces $5 Million Raise in Private Placement Transaction Priced at Market Premium (Business Wire) +6.19% +7.24%
May-09-22 07:00AM	Exicure to Present at Upcoming TIDES USA Oligonucleotide & Peptide Therapeutics Conference (Business Wire) -19.21%
Mar-25-22 04:15PM	Exicure, Inc. Reports Full Year 2021 Financial Results and Corporate Progress (Business Wire) -16.69% -24.15%
Feb-04-22 11:25AM	Chicago CEO steps down after just two months on the job (American City Business Journals)
07:00AM	Exicure, Inc. Announces Leadership Transition and Changes to the Board of Directors (Business Wire)
Jan-05-22 01:38PM	Neville Rodie & Shaw Inc Buys Cleveland-Cliffs Inc, Palo Alto Networks Inc, Novo Nordisk ... (GuruFocus.com) -9.05%
Dec-31-21 07:07PM	Upcoming Deadline Reminder: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire) +11.38%
06:02PM	Exicure Class Action Reminder (NewMediaWire)
02:53PM	UPCOMING DEADLINE ALERT: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (PR Newswire)
01:15PM	SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
Dec-30-21 05:57PM	Exicure Shareholder Notice (NewMediaWire)
03:31PM	Shareholder Action Notice: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
10:00AM	SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
Dec-29-21 11:46PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exicure, Inc. - XCUR (PR Newswire) -8.95%
05:57PM	Exicure Shareholder Alert (NewMediaWire)
04:30PM	Shareholder Action Alert: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
10:45AM	INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
Dec-28-21 05:57PM	Exicure Deadline Alert (NewMediaWire)
02:50PM	Investor Action Reminder: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
10:00AM	INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
Dec-27-21 03:16PM	Shareholder Action Notice: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
11:00AM	SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
Dec-26-21 08:32AM	Exicure Class Action Reminder (NewMediaWire)
Dec-24-21 06:13PM	Exicure Shareholder Notice (NewMediaWire)
01:56PM	Shareholder Action Alert: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
10:40AM	INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
Dec-23-21 08:38PM	ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Exicure, Inc. Investors with Losses to Secure Counsel Before Important February 11 Deadline in Securities Class Action - XCUR (PR Newswire)
09:30AM	INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
Dec-22-21 06:22PM	Bill Gates Slashes Investment in This Penny Biotech Stock (Barrons.com) -7.40%
05:59PM	Exicure Shareholder Notice (NewMediaWire)
04:50PM	Shareholder Action Notice: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
02:32PM	DEADLINE ALERT for RVNC, RAAS, ORGO, and XCUR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders (GlobeNewswire)
11:00AM	XCUR Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Exicure, Inc. Shareholders of Class Action and Encourages Shareholders to Contact the Firm (ACCESSWIRE)
10:00AM	SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
Dec-21-21 05:54PM	Exicure Shareholder Alert (NewMediaWire)
04:08PM	Shareholder Action Alert: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
11:00AM	XCUR Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Exicure, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm (Business Wire)
09:30AM	INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
07:38AM	XCUR Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Exicure, Inc. (XCUR) (Business Wire)
Dec-20-21 05:47PM	Exicure Deadline Alert (NewMediaWire)
03:49PM	Investor Action Reminder: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
11:00AM	XCUR Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Exicure, Inc. Investors of Class Action and Encourages Investors to Contact the Firm (ACCESSWIRE)
11:00AM	INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
10:00AM	Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Exicure, Inc. (XCUR) (Business Wire)
Dec-19-21 09:00PM	EXICURE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Exicure, Inc. and Encourages Investors to Contact the Firm (GlobeNewswire)
08:32AM	Exicure Notice To Shareholders (NewMediaWire)
Dec-17-21 06:13PM	Exicure Class Action Reminder (NewMediaWire)
05:00PM	Contact Firm: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
01:40PM	ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Exicure, Inc. Investors to Secure Counsel Before Important February 11 Deadline in Securities Class Action XCUR (Business Wire)
12:32PM	XCUR Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Exicure, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm (GlobeNewswire)
09:45AM	SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
Dec-16-21 03:50PM	INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
03:00PM	XCUR INVESTOR NOTICE: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Exicure, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action XCUR (GlobeNewswire)
11:00AM	XCUR Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Exicure, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm (ACCESSWIRE)
11:00AM	Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Exicure, Inc. (XCUR) (Business Wire)
12:49AM	INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
Dec-15-21 05:59PM	EXICURE SHAREHOLDER NOTICE (NewMediaWire)
04:00PM	XCUR Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Exicure, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm (PR Newswire)

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DGP Co., Ltd.	10% Owner	Sep 12 '24	Buy	3.00	237,223	711,669	849,223	Sep 16 09:41 PM
DGP Co., Ltd.	10% Owner	Feb 29 '24	Sale	1.32	3,400,000	4,488,000	0	Mar 04 06:36 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

XCUR

Exicure Inc

Upgrade your FINVIZ experience